Press Releases

Bio-Techne Corporation and Regulus Therapeutics announced a collaboration to support Regulus with biomarker analysis for the clinical development of RGLS4326, an Autosomal Dominant Polycystic Kidney Disease (ADPKD) treatment. Regulus has...

EVerZom’s ambition is to transform regenerative medicine and the field of biotherapies thanks to these biological nanoparticles, the extracellular vesicles. EVerZom, a biopharmaceutical company specializing in the bioproduction of extracellular vesicles, announced today that it has obtained €1.1 million in ...

With years of experience in the field of molecular and cell biology research, Creative Biolabs now introduces the cutting-edge exosome quantification platform covering a full list of technologies to detect and quantify exosomes in complex biological samples...

NX Prenatal Inc today announced the publication of new data demonstrating that exosome-associated protein biomarkers derived from first trimester maternal plasma are key in predicting the overall risk of...

Evox Therapeutics, a leading exosome therapeutics company, is pleased to announce that the Company has been granted another key patent by the European Patent Office (EPO). This new grant...

Evox Therapeutics, a leading exosome therapeutics company, is pleased to announce the launch of a collaboration focused on rare diseases with the University of Oxford's Oxford-Harrington Rare Disease Centre embedded within the Department of...

Capricor Therapeutics, Inc. a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class cell- and exosome-based therapeutics for the treatment

Each year ligament injuries sideline thousands of athletes and regular citizens. Recovery is long and painful, and sometimes a return to full function is never realized due to scar formation – a factor that makes ligament injuries prone to further ...

miR Scientific and Puerto Rico government announce pioneering cooperation agreement to evaluate impact and deployment of its prostate cancer liquid biopsy test in Puerto Rico miR Scientific, LLC, a...

miR Scientific, LLC, a healthcare company whose purpose is to transform global cancer management by providing early and highly accurate detection, characterization and monitoring of disease, announced...